ROYCE & ASSOCIATES LP - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 70 filers reported holding IRADIMED CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of IRADIMED CORP
ValueSharesWeighting
Q2 2020$20,000
+17.6%
880
+10.0%
0.00%
Q1 2020$17,000
-22.7%
800
-14.1%
0.00%
Q4 2019$22,000
-4.3%
931
-16.4%
0.00%
Q3 2019$23,000
+64.3%
1,113
+68.1%
0.00%
Q2 2019$14,000
-17.6%
662
+7.5%
0.00%
Q1 2019$17,000
+54.5%
616
+40.6%
0.00%
Q4 2018$11,000
-35.3%
438
-4.8%
0.00%
Q3 2018$17,000
-93.3%
460
-98.7%
0.00%
-100.0%
Q3 2014$254,00036,3000.00%
Other shareholders
IRADIMED CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 715,877$32,100,0004.18%
Soleus Capital Management, L.P. 430,051$19,283,0002.49%
RESOURCE CONSULTING GROUP INC 128,000$5,740,0001.99%
RK Capital 213,200$9,560,0001.88%
Capital Impact Advisors, LLC 22,797$1,022,0000.74%
G2 Investment Partners Management LLC 61,326$2,750,0000.65%
EAM Investors, LLC 76,179$3,416,0000.64%
Ranger Investment Management 193,306$8,668,0000.55%
EAM Global Investors LLC 42,885$1,923,0000.36%
Hillsdale Investment Management Inc. 121,500$5,448,0000.35%
View complete list of IRADIMED CORP shareholders